Requirement For Producer Cell Line For GMP Viral Vector Packaging

A Contract Award Notice
by NHS BLOOD AND TRANSPLANT

Source
Find a Tender
Type
Framework (Supply)
Duration
2 year (est.)
Value
£100K-£111K
Sector
HEALTH
Published
14 Apr 2022
Delivery
To 13 Apr 2024 (est.)
Deadline
n/a

Concepts

Location

Bristol

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

Award Detail

1 Life Technologies (Paisley)
  • Num offers: 1
  • Value: £111,000

Award Criteria

PRICE _

CPV Codes

  • 33141000 - Disposable non-chemical medical consumables and haematological consumables

Indicators

  • Award on basis of price.

Reference

Domains